Europe AI In Cancer Diagnostics Market Size, Share & Industry Trends Analysis Report By End-user (Hospital, Surgical Centers & Medical Institutes), By Component (Software Solutions, Hardware and Services), By Cancer Type, By Country and Growth Forecast, 2022 - 2028

The Europe AI In Cancer Diagnostics Market would witness market growth of 28.0% CAGR during the forecast period (2022-2028).

AI technologies would be applied to crucial oncogenes. Early detection and treatment of cancer improve the chances of a cure. Some cancer cases, such as mouth, skin, testicles, breast, rectum, and prostate can be easily detected by the self-routine checkup and various screening measures before cancer becomes more dangerous and harmful.

Generally, most cancer cases are identified and discovered after the tumor can be perceptible or when other symptoms start appearing. Cancer can also be discovered by treating or examining other medical issues however these happen in a few cases. Cancer can be discovered through the reported testing of the urine, blood, and Stoll abnormalities which may sign of cancer case.

The cases of the neck postmortem are a standard check for the therapy of oral cavity cancer in the authorized head and neck cancer clinics established in Germany. 76% of instances of oral cavity cancer treated in certified centers will involve neck dissections. Head and neck cancers account for about 4% of all tumors in the US. Government spending on healthcare has upraised up to 4% annually in the United Kingdom. During the 1960s, the gross domestic product of healthcare products portraited less than 5% whereas after more than fifty years the GDP hiked up to 10%.

The Germany market dominated the Europe AI In Cancer Diagnostics Market by Country in 2021; thereby, achieving a market value of $33.8 million by 2028. The UK market is exhibiting a CAGR of 27% during (2022 - 2028). Additionally, The France market would experience a CAGR of 29% during (2022 - 2028).

Based on End-user, the market is segmented into Hospital, Surgical Centers & Medical Institutes and Others. Based on Component, the market is segmented into Software Solutions, Hardware and Services. Based on Cancer Type, the market is segmented into Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer & Cervical Cancer, Prostate & Colorectal Cancer and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

Free Valuable Insights: The Global AI In Cancer Diagnostics Market will Hit $509 Million by 2028, at a CAGR of 28.6%

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Microsoft Corporation, Flatiron Health, Paige AI, Inc., PathAI, Inc., Therapixel, Tempus, Inc., SkinVision BV, Cancer Center Sp. z o.o., Medial EarlySign and Kheiron Medical Technologies Limited.

Scope of the Study

Market Segments Covered in the Report:

By End-user

• Hospital
• Surgical Centers & Medical Institutes
• Others

By Component

• Software Solutions
• Hardware
• Services

By Cancer Type

• Breast Cancer
• Lung Cancer
• Brain Tumor
• Skin Cancer & Cervical Cancer
• Prostate & Colorectal Cancer
• Others

By Country

• Germany
• UK
• France
• Russia
• Spain
• Italy
• Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

• Microsoft Corporation
• Flatiron Health
• Paige AI, Inc.
• PathAI, Inc.
• Therapixel
• Tempus, Inc.
• SkinVision BV
• Cancer Center Sp. z o.o.
• Medial EarlySign
• Kheiron Medical Technologies Limited

Unique Offerings from KBV Research

• Exhaustive coverage
• The highest number of Market tables and figures
• Subscription-based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Related Reports:

Global AI In Cancer Diagnostics Market Report 2022-2028

North America AI In Cancer Diagnostics Market Report 2022-2028

Asia Pacific AI In Cancer Diagnostics Market Report 2022-2028

LAMEA AI In Cancer Diagnostics Market Report 2022-2028